SAM
Symphony Asset Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-1,466
| Closed | -$224K | – | 71 |
|
|
2019
Q4 | $224K | Sell |
1,466
-51
| -3% | -$7.79K | 0.05% | 151 |
|
|
2019
Q3 | $201K | Sell |
1,517
-51
| -3% | -$6.76K | 0.04% | 168 |
|
|
2019
Q2 | $222K | Sell |
1,568
-28
| -2% | -$3.96K | 0.05% | 151 |
|
|
2019
Q1 | $232K | Sell |
1,596
-670
| -30% | -$97.4K | 0.06% | 147 |
|
|
2018
Q4 | $256K | Sell |
2,266
-70
| -3% | -$7.91K | 0.08% | 132 |
|
|
2018
Q3 | $314K | Sell |
2,336
-155
| -6% | -$20.8K | 0.08% | 139 |
|
|
2018
Q2 | $278K | Sell |
2,491
-3,815
| -60% | -$426K | 0.06% | 195 |
|
|
2018
Q1 | $673K | Sell |
6,306
-57
| -0.9% | -$6.08K | 0.09% | 207 |
|
|
2017
Q4 | $697K | Sell |
6,363
-186
| -3% | -$20.4K | 0.07% | 219 |
|
|
2017
Q3 | $708K | Sell |
6,549
-445
| -6% | -$48.1K | 0.08% | 221 |
|
|
2017
Q2 | $708K | Buy |
+6,994
| New | +$708K | 0.08% | 222 |
|